Literature DB >> 32375275

Correction: Habibi I. et al. "Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB)" Genes, 2019, 10, 953.

Imen Habibi1, Yosra Falfoul2, Margarita G Todorova3,4, Stefan Wyrsch5, Veronika Vaclavik6, Maria Helfenstein5, Ahmed Turki2, Khaled El Matri2, Leila El Matri2, Daniel F Schorderet1,7,8.   

Abstract

The authors wish to make a correction to the published version of their paper [...].

Entities:  

Year:  2020        PMID: 32375275      PMCID: PMC7288654          DOI: 10.3390/genes11050503

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


The authors wish to make a correction to the published version of their paper [1] because they misread a finding that they cited from the article by Chibani et al. [2] (This reference is cited as [9] in the original text.). In the second paragraph of Section 4.2, the sentence “This alteration was not reported in the 1000 Genome Project or in the ExAC database and was only recently reported in compound heterozygous state [9].” should be changed to “This alteration was not reported in the 1000 Genome Project or in the ExAC database but has recently been found [9].” The authors would like to apologize for any inconvenience caused. The change does not affect the scientific results. The manuscript will be updated and the original will remain online on the article webpage, with a reference to this correction.
  2 in total

1.  Novel BEST1 gene mutations associated with two different forms of macular dystrophy in Tunisian families.

Authors:  Zohra Chibani; Imen Zone Abid; Annette Molbaek; Peter Söderkvist; Jamel Feki; Mounira Hmani-Aifa
Journal:  Clin Exp Ophthalmol       Date:  2019-07-24       Impact factor: 4.207

2.  Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB).

Authors:  Imen Habibi; Yosra Falfoul; Margarita G Todorova; Stefan Wyrsch; Veronika Vaclavik; Maria Helfenstein; Ahmed Turki; Khaled El Matri; Leila El Matri; Daniel F Schorderet
Journal:  Genes (Basel)       Date:  2019-11-21       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.